4cl1: Difference between revisions
No edit summary |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
==The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors== | ==The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors== | ||
<StructureSection load='4cl1' size='340' side='right' caption='[[4cl1]], [[Resolution|resolution]] 3.50Å' scene=''> | <StructureSection load='4cl1' size='340' side='right'caption='[[4cl1]], [[Resolution|resolution]] 3.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4cl1]] is a 4 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4cl1]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Hepatitis_C_virus_(isolate_H77) Hepatitis C virus (isolate H77)]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CL1 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CL1 FirstGlance]. <br> | ||
</td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene>< | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.5Å</td></tr> | ||
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
<table> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cl1 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cl1 OCA], [https://pdbe.org/4cl1 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cl1 RCSB], [https://www.ebi.ac.uk/pdbsum/4cl1 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cl1 ProSAT]</span></td></tr> | ||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/K4KA16_9HEPC K4KA16_9HEPC] | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 12: | Line 16: | ||
The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors.,Lambert SM, Langley DR, Garnett JA, Angell R, Hedgethorne K, Meanwell NA, Matthews SJ Protein Sci. 2014 Mar 18. doi: 10.1002/pro.2456. PMID:24639329<ref>PMID:24639329</ref> | The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors.,Lambert SM, Langley DR, Garnett JA, Angell R, Hedgethorne K, Meanwell NA, Matthews SJ Protein Sci. 2014 Mar 18. doi: 10.1002/pro.2456. PMID:24639329<ref>PMID:24639329</ref> | ||
From | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
<div class="pdbe-citations 4cl1" style="background-color:#fffaf0;"></div> | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Angell | [[Category: Large Structures]] | ||
[[Category: Garnett | [[Category: Angell R]] | ||
[[Category: Hedgethorne | [[Category: Garnett JA]] | ||
[[Category: Lambert | [[Category: Hedgethorne K]] | ||
[[Category: Langley | [[Category: Lambert SM]] | ||
[[Category: Matthews | [[Category: Langley DR]] | ||
[[Category: Meanwell | [[Category: Matthews SJ]] | ||
[[Category: Meanwell NA]] |